Potential non-glycoprotein IIb/IIIa effects of abciximab
Risk stratifying acute coronary syndromes: Gradient of risk and benefit
Glycoprotein IIb/IIIa blockade and thrombolytics: Early lessons from the SPEED and GUSTO IV trials
Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization
Economic issues in glycoprotein IIb/IIIa receptor therapy
Readministration of abciximab: Interim report of the ReoPro Readministration Registry
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: Fact or fancy?